To further confirm SCD1 target specificity for SSI-(1-4), we repeated the proliferative challenge in RCC cell lines in the presence of exogenous oleic acid (OA), which demonstrates rescue of the cytotoxic defects induced by SCD1 inhibitors [6]. The gene discussed is SCD; the disease is renal cell carcinoma.